• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液管理:临床医生入门指南。

Blood management: a primer for clinicians.

作者信息

Boucher Bradley A, Hannon Timothy J

机构信息

Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.

出版信息

Pharmacotherapy. 2007 Oct;27(10):1394-411. doi: 10.1592/phco.27.10.1394.

DOI:10.1592/phco.27.10.1394
PMID:17896895
Abstract

Blood transfusions are common in the hospital setting. Despite the large commitment of resources to the delivery of blood components, many clinicians have only a vague understanding of the complexities associated with blood management and transfusion therapy. The purpose of this primer is to broaden the awareness of health care practitioners in terms of the risks versus benefits of blood transfusions, their economics, and alternative treatments. By developing and implementing comprehensive blood management programs, hospitals can promote safe and clinically effective blood utilization practices. The cornerstones of blood management programs are the implementation of evidence-based transfusion guidelines to reduce variability in transfusion practice, and the employment of multidisciplinary teams to study, implement, and monitor local blood management strategies. Pharmacists can play a key role in blood management programs by providing technical expertise as well as oversight and monitoring of pharmaceutical agents used to reduce the need for allogeneic blood.

摘要

输血在医院环境中很常见。尽管在血液成分供应方面投入了大量资源,但许多临床医生对与血液管理和输血治疗相关的复杂性只有模糊的认识。本入门指南的目的是提高医疗从业者对输血的风险与益处、其经济学以及替代治疗方法的认识。通过制定和实施全面的血液管理计划,医院可以促进安全且临床有效的血液使用实践。血液管理计划的基石是实施基于证据的输血指南以减少输血实践中的变异性,以及组建多学科团队来研究、实施和监测当地的血液管理策略。药剂师可以在血液管理计划中发挥关键作用,提供专业技术知识以及对用于减少异体输血需求的药物进行监督和监测。

相似文献

1
Blood management: a primer for clinicians.血液管理:临床医生入门指南。
Pharmacotherapy. 2007 Oct;27(10):1394-411. doi: 10.1592/phco.27.10.1394.
2
Clinicians as gatekeepers: what is the best route to optimal blood use?临床医生作为把关者:实现最佳用血的最佳途径是什么?
Dev Biol (Basel). 2007;127:9-14.
3
Blood utilization: fostering an effective hospital transfusion culture.血液利用:培养有效的医院输血文化。
J Clin Anesth. 2012 Mar;24(2):155-63. doi: 10.1016/j.jclinane.2011.06.020.
4
Economic considerations on transfusion medicine and patient blood management.输血医学和患者血液管理的经济学考虑。
Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):59-68. doi: 10.1016/j.bpa.2013.02.001.
5
Saving lives and conserving blood: changing blood transfusion practices at St. John's Hospital, Springfield, Missouri.
Mo Med. 2003 Nov-Dec;100(6):586-9.
6
Risk management strategies for home transfusion therapy.家庭输血治疗的风险管理策略。
J Intraven Nurs. 1997 Jul-Aug;20(4):179-87.
7
Adverse blood transfusion outcomes: establishing causation.不良输血结局:确定病因。
Transfus Med Rev. 2011 Apr;25(2):89-101. doi: 10.1016/j.tmrv.2010.11.001. Epub 2011 Feb 23.
8
Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.圣地亚哥退伍军人事务医疗系统急性心力衰竭管理的关键路径:将绩效指标转化为心脏护理。
Crit Pathw Cardiol. 2008 Sep;7(3):153-72. doi: 10.1097/HPC.0b013e31818207e4.
9
Practical considerations when developing guidelines for managing critical bleeding.
Pharmacotherapy. 2007 Sep;27(9 Pt 2):103S-109S. doi: 10.1592/phco.27.9part2.103S.
10
The clinician's approach to the management of risk.
Transfus Sci. 1994 Mar;15(1):37-48. doi: 10.1016/0955-3886(94)90049-3.

引用本文的文献

1
Review of Evidence Supporting the Arista™ Absorbable Powder Hemostat.支持Arista™可吸收止血粉的证据综述。
Med Devices (Auckl). 2024 May 21;17:173-188. doi: 10.2147/MDER.S442944. eCollection 2024.
2
New horizons for reduction of blood use: Patient blood management.减少血液使用的新视野:患者血液管理。
Asian J Transfus Sci. 2023 Jan-Jun;17(1):108-116. doi: 10.4103/ajts.ajts_14_21. Epub 2022 Dec 12.
3
Isolation, Characterization and Evaluation of Collagen from Jellyfish Rhopilema esculentum Kishinouye for Use in Hemostatic Applications.
用于止血应用的海蜇(海蜇)胶原蛋白的分离、表征及评价
PLoS One. 2017 Jan 19;12(1):e0169731. doi: 10.1371/journal.pone.0169731. eCollection 2017.
4
S2'-subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor -2 domain1-wild-type, Leu17Arg-mutant and aprotinin.人源和鼠源酶(纤溶酶、因子XIa、激肽释放酶)之间S2'亚位点的差异阐明了组织因子途径抑制剂-2结构域1野生型、Leu17Arg突变体和抑肽酶的抑制差异。
J Thromb Haemost. 2016 Dec;14(12):2509-2523. doi: 10.1111/jth.13538. Epub 2016 Nov 19.
5
Transfusion monitoring: care practice analysis in a public teaching hospital.输血监测:一所公立教学医院的护理实践分析
Einstein (Sao Paulo). 2016 Jan-Mar;14(1):41-6. doi: 10.1590/S1679-45082016AO3555.
6
Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses.法国医院各类诊断手术后出血相关并发症的发生率及费用
BMC Health Serv Res. 2013 May 22;13:186. doi: 10.1186/1472-6963-13-186.